Chromium Nicotinate
Chromium nicotinate is chromium bound to nicotinic acid (niacin). Like other supplemental chromium forms (picolinate, polynicotinate, chromium yeast), it's promoted for glycemic control and insulin sensitivity in type 2 diabetes. The chromium evidence base is modest and inconsistent overall — and crucially, no form has consistently outperformed the others in head-to-head trials. Pick the form based on price and quality, not because of marketing claims of superior bioavailability.
Quick decision guide
May help most
Adults with type 2 diabetes or insulin resistance who want a low-cost trial of chromium as an adjunct to standard glycemic management — and who don't have a preference between nicotinate, picolinate, polynicotinate, or chromium yeast.
Common dosing range
200–1,000 µg elemental chromium/day. Trials in T2DM most often used 200–600 µg/day.
When to expect effects
8–12 weeks minimum to assess HbA1c or fasting glucose change.
Watch out for
Don't replace prescribed diabetes medications with chromium. Some hypoglycemia risk when combined with insulin or sulfonylureas — monitor glucose.
Evidence snapshot
What is it
Chromium nicotinate is chromium bound to nicotinic acid (niacin). Similar to chromium polynicotinate but typically with a different chromium-to-niacin ratio.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
Glycemic control in type 2 diabetes (adjunct) Limited Evidence | HbA1c −0.55% pooled (chromium overall, modest); fasting glucose modest reduction; high heterogeneity across trials | Adults with T2DM or insulin resistance on stable standard therapy; possibly stronger in chromium-deficient subgroups (older adults, parenteral nutrition recipients) | 8–12 weeks minimum to assess change |
Body composition (fat loss, muscle) Mixed Evidence | No significant difference vs placebo in body composition or strength in 12-week trial | None established | Not established for body composition |
Carbohydrate craving / mood (in atypical depression) Mixed Evidence | Inconsistent small effect on carbohydrate-craving symptoms; not replicated for the nicotinate form | None established for nicotinate form | 8 weeks in trial protocols |
Glycemic control in type 2 diabetes (adjunct)
- Effect
- HbA1c −0.55% pooled (chromium overall, modest); fasting glucose modest reduction; high heterogeneity across trials
- Best fit
- Adults with T2DM or insulin resistance on stable standard therapy; possibly stronger in chromium-deficient subgroups (older adults, parenteral nutrition recipients)
- Time
- 8–12 weeks minimum to assess change
Body composition (fat loss, muscle)
- Effect
- No significant difference vs placebo in body composition or strength in 12-week trial
- Best fit
- None established
- Time
- Not established for body composition
Carbohydrate craving / mood (in atypical depression)
- Effect
- Inconsistent small effect on carbohydrate-craving symptoms; not replicated for the nicotinate form
- Best fit
- None established for nicotinate form
- Time
- 8 weeks in trial protocols
Evidence for 3 uses
AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.
Glycemic control in type 2 diabetes (adjunct)
Disease adjunctSuksomboon 2014 pooled 25 RCTs of chromium supplementation in T2DM and found a modest HbA1c reduction (−0.55%, 95% CI −0.88 to −0.22). Effects were inconsistent and heterogeneity was high. No specific form (picolinate, nicotinate, polynicotinate, or yeast) consistently outperformed the others. Chromium nicotinate trials are mostly within the broader chromium literature without head-to-head differentiation. Use as a low-risk adjunct to standard diabetes care, not a substitute.
Bottom line: Modest adjunct effect at best. Pick the chromium form on price and brand quality — nicotinate isn't measurably better than picolinate or polynicotinate.
Body composition (fat loss, muscle)
Supplement benefitLukaski 2007 randomized overweight women to chromium picolinate, chromium nicotinate, or placebo during a 12-week resistance training programme. No significant differences in body composition, strength, or insulin sensitivity between forms or vs placebo. The broader chromium-and-weight-loss literature similarly shows weak, inconsistent effects. Chromium nicotinate is not a fat-loss supplement.
Bottom line: Skip for weight loss. The protein-calorie equation is what changes body composition.
Carbohydrate craving / mood (in atypical depression)
Supplement benefitA small set of older trials with chromium picolinate (not nicotinate specifically) suggested a possible benefit in atypical depression with carbohydrate craving. Effects were small, the trials were short, and replication has been inconsistent. There is no specific nicotinate-form data for this indication.
Bottom line: Don't rely on chromium-nicotinate for mood. Discuss depression treatment with a clinician.
How it works
How to take it
What to track
Bottom line: If you and your clinician decide a chromium trial is reasonable, 200–600 µg elemental chromium/day for 8–12 weeks is enough to evaluate. No need to pay a premium for one form over another.
5 commercial forms
Compare the main delivery options and what they’re best suited for.
Chromium nicotinate (this page)
Niacin-boundChromium chelated 1:1 (or similar) to nicotinic acid. Better absorbed than chromium chloride; comparable to picolinate and polynicotinate in head-to-head data. The niacin component adds a small dose of nicotinic acid per serving — usually inconsequential.
Comparable to picolinate and polynicotinate.
Chromium polynicotinate
Higher Cr:niacin ratioChromium bound to multiple nicotinic-acid groups (often branded ChromeMate). Marketed as more bioavailable than picolinate; head-to-head clinical data don't clearly support superiority. See /nutrients/chromium-polynicotinate.
Comparable to nicotinate and picolinate in clinical trials.
Chromium picolinate
Most studiedChromium bound to picolinic acid. The form used in most large T2DM glycemic-control trials. Some old safety questions about picolinic acid signaling were never substantiated in clinical use. See /nutrients/chromium-picolinate.
Equivalent to nicotinate and polynicotinate in head-to-head trials.
Chromium yeast (Saccharomyces cerevisiae)
Food-formChromium incorporated into yeast biomass; arguably the most 'food-like' source. Bioavailability per µg is comparable to chelated chromium forms; some prefer it for the food-matrix delivery.
Comparable in absorption and effect to chelated forms.
Chromium chloride
Lower absorptionInorganic chromium salt. Lower bioavailability than chelated forms. Used in older clinical trials but largely superseded by picolinate/nicotinate/polynicotinate in modern supplements.
Lowest of the supplemental forms; superseded by chelates.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Hypoglycemia risk when combined with insulin or sulfonylureas — monitor blood glucose if starting chromium on top of these medications.
Rare reports of acute renal injury with very-high-dose chronic chromium (≥1,200 µg/day for prolonged periods). Keep daily dose ≤1,000 µg unless directed by a clinician.
The niacin portion of chromium nicotinate can contribute to flushing or hepatic enzyme elevation at very high cumulative niacin intake — usually inconsequential at typical chromium doses (<500 µg/day = <~10 mg niacin) but watch if combined with other niacin-containing supplements.
Who should avoid it
- People with kidney disease or transplant recipients — chronic mineral supplementation should be cleared with your nephrologist.
- People with liver disease — niacin component may add to hepatic load at higher cumulative doses.
- Pregnant or breastfeeding women without medical input.
- People on insulin or sulfonylureas without diabetes-care coordination — risk of hypoglycemia.
Pregnancy & breastfeeding
Adequate Intake of chromium in pregnancy is 30 µg/day (lactation 45 µg/day); ordinary diet typically supplies enough. Supplemental chromium beyond AI hasn't been studied in pregnancy and should be discussed with your obstetric provider.
Bottom line: Generally low-risk at supplement doses. The main practical caution is hypoglycemia with insulin/sulfonylureas — monitor glucose if you start chromium on top of those.
Interactions
Additive glucose-lowering effect — risk of hypoglycemia. Monitor blood glucose and discuss dose adjustment with your diabetes-care clinician.
Mild additive insulin-sensitising effect. No specific dose adjustment required; monitor glucose.
Trivalent chromium may modestly reduce levothyroxine absorption. Separate doses by 3–4 hours.
Chromium and iron may modestly compete for transferrin binding; clinical significance is low. Separate by 2 hours if both are essential.
May reduce chromium absorption when taken together. Separate by 1–2 hours.
Chromium nicotinate contributes a small amount of nicotinic acid per dose. Stacking with high-dose niacin products can push you toward niacin-flush, hepatic enzyme elevation, or hyperuricemia.
Food sources
| Food | Amount | %DV |
|---|---|---|
| Broccoli, cooked | ½ cup (~11 µg Cr) | 31% |
| Grape juice | 1 cup (~8 µg Cr) | 23% |
| Turkey breast, roasted | 3 oz (~1.7 µg Cr) | 5% |
| Whole wheat English muffin | 1 muffin (~4 µg Cr) | 11% |
| Green beans, cooked | ½ cup (~1.1 µg Cr) | 3% |
| Beef, ground, cooked | 3 oz (~2 µg Cr) | 6% |
| Apple, with skin | 1 medium (~1.4 µg Cr) | 4% |
| Brewer's yeast (chromium-enriched) | 1 Tbsp (variable, ~10–50 µg Cr) | — |
Broccoli, cooked
- Amount
- ½ cup (~11 µg Cr)
- %DV
- 31%
Grape juice
- Amount
- 1 cup (~8 µg Cr)
- %DV
- 23%
Turkey breast, roasted
- Amount
- 3 oz (~1.7 µg Cr)
- %DV
- 5%
Whole wheat English muffin
- Amount
- 1 muffin (~4 µg Cr)
- %DV
- 11%
Green beans, cooked
- Amount
- ½ cup (~1.1 µg Cr)
- %DV
- 3%
Beef, ground, cooked
- Amount
- 3 oz (~2 µg Cr)
- %DV
- 6%
Apple, with skin
- Amount
- 1 medium (~1.4 µg Cr)
- %DV
- 4%
Brewer's yeast (chromium-enriched)
- Amount
- 1 Tbsp (variable, ~10–50 µg Cr)
- %DV
- —
Choosing a product
What to look for on the label — and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
Is chromium nicotinate the same as chromium polynicotinate?⌄
Similar but with different niacin-to-chromium ratios. Both deliver chromium with niacin binding.
References by claim
Track Chromium Nicotinate with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.
Coming to App StoreDisclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.